The trading of Microbio securities in centralized securities exchange market follows Announcement or Notice of Attention to Trading Information

Microbio (Shanghai) submitted an IND to US FDA for a phase I clinical trial on the broad-spectrum anti-SARS- CoV-2 siRNA (SNS812) co-developed with Oneness

Announce on behalf of major subsidiary Cotton Field Organic Co., Ltd.on matters related to the full non-physical issuance of shares

Announce on behalf of major subsidiary Cotton Field Organic Co., Ltd. about the resolution that the Ex-rights record date of new shares from earnings by BOD

Announcement of the BOD resolved to release of non-compete restrictions for the manager

Announce the new appointment of the general manager

The Board of Directors Approved the 2022 Q2 Consolidated Financial Statements